Attenuation of MHC class II expression in macrophages infected with Mycobacterium bovis bacillus Calmette-Guerin involves class II transactivator and depends on the Nramp1 gene

Journal of Immunology

Volumn 163, Issue 5, 1999, Pages 2688-2696

  Wojciechowski, Wojciech ^a   Desanctis, Juan ^b   Skamene, Emil ^a   Radzioch, Danuta ^a,c  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CELL PROTEIN; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; STAT1 PROTEIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL INFECTION; DOWN REGULATION; GENE LOCUS; INFECTION RESISTANCE; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION;

ANIMALS; CARRIER PROTEINS; CATION TRANSPORT PROTEINS; CELL LINE; DISEASE SUSCEPTIBILITY; GENE EXPRESSION REGULATION; GENES, MHC CLASS II; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNITY, NATURAL; INTERFERON TYPE II; INTERFERON-STIMULATED GENE FACTOR 3; MACROPHAGES; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; MYCOBACTERIUM BOVIS; NUCLEAR PROTEINS; PHOSPHORYLATION; RNA, MESSENGER; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TYROSINE;

EID: 0033197959     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. Cellier, M., A. Belouchi, and P. Gros. 1996. Resistance to intracellular infections: comparative genomic analysis of Nramp. Trends Genet. 12:201.
2. Belouchi, A., M. Cellier, T. Kwan, H. S. Saini, G. Leroux, and P. Gros. 1995. The macrophage-specific membrane protein Nramp controlling natural resistance to infections in mice has homologues expressed in the root system of plants. Plant Mol. Biol. 29:1181.
3. West, A. H., D. J. Clark, J. Martin, W. Neupert, F. U. Hartl, and A. L. Horwich. 1992. Two related genes encoding extremely Hydrophobic proteins suppress a lethal mutation in the yeast mitochondrial processing enhancing protein. J. Biol. Chem. 267:24625.
4. Rodrigues, V., P. Y. Cheah, K. Ray, and W. Chia. 1995. malvolio, the Drosophila homologue of mouse Nramp-1 (Bcg), is expressed in macrophages and in the nervous system and is required for normal taste behavior. EMBO J. 14:3007.
5. Hu, J., N. Bumstead, E. Skamene, P. Gros, and D. Malo. 1996. Structural organization, sequence, and expression of the chicken NRAMP1 gene encoding the natural resistance-associated macrophage protein 1. DNA Cell Biol. 15:113.
6. Cellier, M., G. Govoni, S. Vidal, T. Kwan, N. Groulx, J. Liu, F. Sanchez, E. Skamene, E. Schurr, and P. Gros. 1994. Human natural resistance-associated macrophage protein: cDNA cloning, chromosomal mapping, genomic organization, and tissue-specific expression. J. Exp. Med. 180:1741.
7. Vidal, S. M., D. Malo, K. Vogan, E. Skamene, and P. Gros. 1993. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 73:469.
8. Govoni, G., S. Vidal, S. Gauthier, E. Skamene, D. Malo, and P. Gros. 1996. The Bcg/Ity/Lsh locus: genetic transfer of resistance to infections in C57BL/6J mice transgenic for the Nramp1 Gly169 allele. Inject. Immun. 64:2923.
9. Lang, T., E. Prina, D. Sibthorpe, and J. M. Blackwell. 1997. Nramp1 transfection transfers Ity/Lsh/Bcg-related pleiotropic effects on macrophage activation: influence on antigen processing and presentation. Infect. Immun. 65:380.
10. Cellier, M., G. Prive, A. Belouchi, T. Kwan, V. Rodrigues, W. Chia, and P. Gros. 1995. Nramp defines a family of membrane proteins. Proc. Natl. Acad. Sci. USA 92:10089.
11. Barton, C. H., J. K. White, T. I. Roach, and J. M. Blackwell. 1994. NH2-terminal sequence of macrophage-expressed natural resistance-associated macrophage protein (Nramp) encodes a proline/serine-rich putative Src homology 3-binding domain. J. Exp. Med. 179:1683.
12. Supek, F., L. Supekova, H. Nelson, and N. Nelson. 1996. A yeast manganese transporter related to the macrophage protein involved in conferring resistance to mycobacteria. Proc. Natl. Acad. Sci. USA 93:5105.
13. Gruenheid, S., M. Cellier, S. Vidal, and P. Gros. 1995. Identification and characterization of a second mouse Nramp gene. Genomics 25:514.
14. Gruenheid, S., E. Pinner, M. Desjardins, and P. Gros. 1997 Natural resistance to infection with intracellular pathogens: the Nramp1 protein is recruited to the membrane of the phagosome. J. Exp. Med. 185:717.
15. Hackam, D. J., O. D. Rotstein, W. Zhang, S. Gruenheid, P. Gros, and S. Grinstein. 1998. Host resistance to intracellular infection: mutation of natural resistance-associated macrophage protein 1 (Nramp1) impairs phagosomal acidification. J. Erp. Med. 188:351.
16. Vidal, S., P. Gros, and E. Skamene. 1995. Natural resistance to infection with intracellular parasites: molecular genetics identifies Nramp1 as the Bcg/Ity/Lsh locus. J. Leukocyte Biol. 58:382.
17. Fearon, D. T., and R. M. Locksley. 1996. The instructive role of innate immunity in the acquired immune response. Science 272:50.
18. Stach, J. L., P. Gros, A. Forget, and E. Skamene. 1984. Phenotypic expression of genetically-controlled natural resistance to Mycobacterium bovis (BCG). J. Immunol. 132:888.
19. Lissner, C. R., R. N. Swanson, and A. D. O'Brien. 1983. Genetic control of the innate resistance of mice to Salmonella typhimurium: expression of the Ity gene in peritoneal and splenic macrophages isolated in vitro. J. Immunol. 131:3006.
20. Olivier, M., and C. E. Tanner. 1987. Susceptibilities of macrophage populations to infection in vitro by Leishmania donovani. Infect. Immun. 55:467.
21. Green, S. J., M. S. Meltzer, J. B. Hibbs, Jr., and C. A. Nacy. 1990. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J. Immunol. 144:278.
22. Evans, T. G., L. Thai, D. L. Granger, and J. B. Hibbs, Jr. 1993. Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis. J. Immunol. 151:907.
23. Mauel, J., A. Ransijn, and Y. Buchmuller-Rouiller. 1991. Killing of Leishmania parasites in activated murine macrophages is based on an L-arginine-dependent process that produces nitrogen derivatives. J. Leukocyte Biol. 49:73.
24. Roach, T. I., A. F. Kiderlen, and J. M. Blackwell. 1991. Role of inorganic nitrogen oxides and tumor necrosis factor α in killing Leishmania donovani amastigotes in γ interferon-lipopolysaccharide-activated macrophages from Lshs and Lshr congenic mouse strains. Infect. Immun. 59:3935.
25. Denis, M. 1991. Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell Immunol 132:150.
26. Chan, J., Y. Xing, R. S. Magliozzo, and B. R. Bloom. 1992. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 175:1111.
27. Barrera, L. F., I. Kramnik, E. Skamene, and D. Radzioch. 1994. Nitrite production by macrophages derived from BCG-resistant and -susceptible congenic mouse strains in response to IFN-γ and infection with BCG. Immunology 82:457.
28. Rojas, M., L. F. Barrera, G. Puzo, and L. F. Garcia. 1997. Differential induction of apoptosis by virulent Mycobacterium tuberculosis in resistant and susceptible murine macrophages: role of nitric oxide and mycobacterial products. J. Immunol. 159:1352.
29. Schurr, E., D. Radzioch, D. Malo, P. Gros, and E. Skamene. 1991. Molecular genetics of inherited susceptibility to intracellular parasites. Behring Inst. Mitt. :1.
30. Blackwell, J. M., C. H. Barton, J. K. White, T. I. Roach, M. A. Shaw, S. H. Whitehead, B. A. Mock, S. Searle, H. Williams, and A. M. Baker. 1994. Genetic regulation of leishmanial and mycobacterial infections: the Lsh/Ity/Bcg gene story continues. Immunol. Lett. 43:99.
31. Skamene, E. 1994. The Bcg gene story. Immunobiology 191:451.
32. Radzioch, D., I. Kramnik, and E. Skamene. 1994. Molecular mechanisms of natural resistance to mycobacterial infections. Circ. Shock 44:115.
33. Barrera, L. F., I. Kramnik, E. Skamene, and D. Radzioch. 1997. I-A beta gene expression regulation in macrophages derived from mice susceptible or resistant to infection with M. bovis BCG. Mol. Immunol. 34:343.
34. Schwartz, R. H. 1986. Immune response (Ir) genes of the murine major histocompatibility complex. Adv. Immunol. 38:31.
35. Mengle-Gaw, L., and H. O. McDevitt. 1985. Genetics and expression of mouse Ia antigens. Annu. Rev. Immunol. 3:367.
36. Glimcher, L. H., and C. J. Kara. 1992. Sequences and factors: a guide to MHC class-II transcription. Annu. Rev. Immunol. 10:13.
37. Ting, J. P., and A. S. Baldwin. 1993. Regulation of MHC gene expression. Curr. Opin. Immunol. 5:8.
38. Reith, W., V. Steimle, and B. Mach. 1995. Molecular defects in the bare lymphocyte syndrome and regulation of MHC class II genes. Immunol. Today 16:539.
39. Mach, B., V. Steimle, E. Martinez-Soria, and W. Reith. 1996. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14:301.
40. Muhlethaler-Mottet, A., L. A. Otten, V. Steimle, and B. Mach. 1997. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J. 16:2851.
41. Brown, J. A., E. M. Rogers, and J. M. Boss. 1998. The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element. Nucleic Acids Res. 26:4128.
42. Steimle, V., L. A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135.
43. Riley, J. L., S. D. Westerheide, J. A. Price, J. A. Brown, and J. M. Boss. 1995. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity 2:533.
44. Zhou, H., and L. H. Glimcher. 1995. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 2:545.
45. Chin, K. C., G. G. Li, and J. P. Ting. 1997. Importance of acidic, proline/serine/ threonine-rich, and GTP-binding regions in the major histocompatibility complex class II transactivator: generation of transdominant-negative mutants. Proc. Natl. Acad. Sci. USA 94:2501.
46. Lee, Y. J., Y. Han, H. T. Lu, V. Nguyen, H. Qin, P. H. Howe, B. A. Hocevar, J. M. Boss, R. M. Ransohoff, and E. N. Benveniste. 1997. TGF-β suppresses IFN-γ induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression. J. Immunol. 158:2065.
47. Piskurich, J. F., Y. Wang, M. W. Linhoff, L. C. White, and J. P. Ting. 1998. Identification of distinct regions of 5′ flanking DNA that mediate constitutive, IFN-γ, STAT1, and TGF-β-regulated expression of the class II transactivator gene. J. Immunol. 160:233.
48. Bach, E. A., M. Aguet, and R. D. Schreiber. 1997. The IFN γ receptor: a paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 15:563.
49. Leonard, W. J., and J. J. O'Shea. 1998. Jaks and STATs: biological implications. Annu. Rev. Immunol. 16:293.
50. Darnell, J. E., Jr., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415.
51. Vidal, S., M. L. Tremblay, G. Govoni, S. Gauthier, G. Sebastiani, D. Malo, E. Skamene, M. Olivier, S. Jothy, and P. Gros. 1995. The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J. Exp. Med. 182:655.
52. Radzioch, D., T. Hudson, M. Boule, L. Barrera, J. W. Urbance, L. Varesio, and E. Skamene. 1991. Genetic resistance/susceptibility to mycobacteria: phenotypic expression in bone marrow derived macrophage lines. J. Leukocyte Biol. 50:263.
53. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294.
54. Lee, Y. J., and E. N. Benveniste. 1996. Stat1α expression is involved in IFN-γ induction of the class II transactivator and class II MHC genes. J. Immunol. 157:1559.
55. Gunshin, H., B. Mackenzie, U. V. Berger, Y. Gunshin, M. F. Romero, W. F. Boron, S. Nussberger, J. L. Gollan, and M. A. Hediger. 1997. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388:482.
56. Atkinson, P. G., J. M. Blackwell, and C. H. Barton. 1997. Nramp1 locus encodes a 65 kDa interferon-γ-inducible protein in murine macrophages. Biochem. J. 325:779.
57. Supek, F., L. Supekova, H. Nelson, and N. Nelson. 1997. Function of metal-ion homeostasis in the cell division cycle, mitochondrial protein processing, sensitivity to mycobacterial infection and brain function. J. Exp. Biol. 200:321.
58. Roach, T. I., D. Chatterjee, and J. M. Blackwell. 1994. Induction of early-response genes KC and JE by mycobacterial lipoarabinomannans: regulation of KC expression in murine macrophages by Lsh/Ity/Bcg (candidate Nramp). Infect. Immun. 62:1176.
59. Barrera, L. F., E. Skamene, and D. Radzioch. 1993. Assessment of mycobacterial infection and multiplication in macrophages by polymerase chain reaction. J. Immunol. Methods 157:91.
60. Olivier, M., P. Cook, J. Desanctis, Z. Hel, W. Wojciechowski, N. E. Reiner, E. Skamene, and D. Radzioch. 1998. Phenotypic difference between Bcg(r) and Bcg(s) macrophages is related to differences in protein-kinase-C-dependent signalling. Eur. J. Biochem. 251:734.
61. Luder, C. G., T. Lang, B. Beuerle, and U. Gross. 1998. Down-regulation of MHC class II molecules and inability to up-regulate class I molecules in murine macrophages after infection with Toxoplasma gondii. Clin. Exp. Immunol. 112:308.
62. Fruth, U., N. Solioz, and J. A. Louis. 1993. Leishmania major interferes with antigen presentation by infected macrophages. J. Immunol. 150:1857.
63. Engelhorn S., A. Bruckner, and H. G. Remold. 1990. A soluble factor produced by inoculation of human monocytes with Leishmania donovani promastigotes suppresses IFN-γ-dependent monocyte activation. J. Immunol. 145:2662.
64. Reiner, N. E., W. Ng, and W. R. McMaster. 1987. Parasite-accessory cell interactions in murine leishmaniasis. II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility complex gene products. J. Immunol. 138:1926.
65. Heise, M. T., M. Connick, and H. W. T. Virgin. 1998. Murine cytomegalovirus inhibits interferon γ-induced antigen presentation to CD4 T cells by macrophages via regulation of expression of major histocompatibility complex class II-associated genes. J. Exp. Med. 187:1037.
66. Wadee, A. A., R. H. Kuschke, T. G. Dooms, and R. Anderson. 1995. The prooxidative riminophenazine B669 neutralizes the inhibitory effects of Mycobacterium tuberculosis on phagocyte antimicrobial activity. Int. J. Immunopharmacol. 17:849.
67. Wadee, A. A., R. H. Kuschke, and T. G. Dooms. 1995. The inhibitory effects of Mycobacterium tuberculosis on MHC class II expression by monocytes activated with riminophenazines and phagocyte stimulants. Clin. Exp. Immunol. 100:434.
68. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259:1739.
69. Kamijo, R., D. Shapiro, J. Gerecitano, J. Le, M. Bosland, and J. Vilcek. 1994. Biological functions of IFN-γ and IFN-α/β: lessons from studies in gene knock-out mice. Hokkaido J. Med. Sci. 69:1332.
70. Boss, J. M. 1997. Regulation of transcription of MHC class II genes. Curr. Opin. Immunol. 9:107.
71. Bradley, M. B., J. M. Fernandez, G. Ungers, T. Diaz-Barrientos, V. Steimle, B. Mach, R. O'Reilly, and J. S. Lee. 1997. Correction of defective expression in MHC class II deficiency (bare lymphocyte syndrome) cells by retroviral transduction of CIITA. J. Immunol. 159:1086.
72. Chang, C. H., J. D. Fontes, M. Peterlin, and R. A. Flavell. 1994. Class II trans-activator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180:1367.
73. Vespa, L., and B. S. Zwilling. 1989. Expression of I-A by macrophages from Bcgr and Begs mice. Transient expression of I-A is due to degradation of MHC class II glycoproteins. J. Immunol. 143:214.
74. Zwilling, B. S., L. Vespa, and M. Massie. 1987. Regulation of I-A expression by murine peritoneal macrophages: differences linked to the Beg gene. J. Immunol. 138:1372.
75. Vespa, L., S. C. Johnson, W. A. Aldrich, and B. S. Zwilling. 1987. Modulation of macrophage I-A expression: lack of effect of prostaglandins and glucocorticoids on macrophages that continuously express I-A. J. Leukocyte Biol. 41:47.
76. Gonalons, E., M. Barrachina, J. A. Garcia-Sanz, and A. Celada. 1998. Translational control of MHC class II I-A molecules by IFN-γ. J. Immunol. 161:1837.
77. Atkinson, P. G., and C. H. Barton. 1998. Ectopic expression of Nramp1 in COS-1 cells modulates iron accumulation. FEBS Lett. 425:239.